Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD): A Prospective, Multicenter, Randomized, Controlled Trial

NCT04624854 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.

NCT NCT04624854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04624854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD): A Prospective, Multicenter, Randomized, Controlled Trial
Lead sponsor
Harbin Medical University
Phase
Phase 4
Overall status
Completed
Start date
October 28, 2020
Completion date
September 23, 2025
Enrollment
8,250 (actual)
Sites
97

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, arterial occlusive diseases, arteriosclerosis, cardiovascular diseases, coronary artery disease, coronary disease, heart diseases, myocardial ischemia, syndrome heart disease, vascular diseases